Alligator Bioscience AB (publ) (STO:ATORX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1934
+0.0112 (6.15%)
Mar 4, 2026, 5:17 PM CET

Alligator Bioscience AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
0.5157.7758.1135.712.94
Other Revenue
3.91-0.041.140.310.38
4.4257.7259.253613.33
Revenue Growth (YoY)
-92.34%-2.58%64.58%170.14%141.65%
Cost of Revenue
77.5167.21218.79147.7386.98
Gross Profit
-73.07-109.48-159.54-111.72-73.66
Selling, General & Admin
43.2970.4379.3868.8456.85
Other Operating Expenses
1.46-0.12-0.02-0.03-0
Operating Expenses
46.71119.0489.8580.5868
Operating Income
-119.78-228.52-249.39-192.3-141.65
Interest Expense
-44.27-19.69-0.48-0.65-0.23
Interest & Investment Income
0.271.311.88--
Currency Exchange Gain (Loss)
0.83-1.27-0.6-0.46-0.14
Other Non Operating Income (Expenses)
99.414.2800-
EBT Excluding Unusual Items
-63.55-233.89-248.59-193.41-142.03
Asset Writedown
12.2----
Other Unusual Items
-----0.96
Pretax Income
-51.35-233.89-248.59-193.4-141.74
Net Income
-51.35-233.89-248.59-193.4-141.74
Net Income to Common
-51.35-233.89-248.59-193.4-141.74
Shares Outstanding (Basic)
281000
Shares Outstanding (Diluted)
281000
Shares Change (YoY)
3648.83%63.72%103.32%146.00%25.61%
EPS (Basic)
-1.87-318.53-554.27-876.77-1580.64
EPS (Diluted)
-1.87-320.00-554.27-880.00-1580.64
Free Cash Flow
-157.45-212.43-191.74-173.05-127.08
Free Cash Flow Per Share
-5.72-289.30-427.53-784.49-1417.17
Gross Margin
--189.67%-269.26%--
Operating Margin
-2708.14%-395.90%-420.90%-534.16%-1062.89%
Profit Margin
-1160.98%-405.19%-419.55%-537.22%-1063.52%
Free Cash Flow Margin
-3559.71%-368.01%-323.61%-480.67%-953.54%
EBITDA
-117.82-227.58-248.24-188.89-136.7
D&A For EBITDA
1.960.951.153.414.95
EBIT
-119.78-228.52-249.39-192.3-141.65
Revenue as Reported
6.4259.7161.937.1415.13
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.